


IdentifySensors Revenue
Biotechnology Research • Shaker Heights, Ohio, United States • 11-20 Employees
IdentifySensors revenue & valuation
| Annual revenue | $1,026,660 |
| Revenue per employee | $86,000 |
| Estimated valuation?This valuation is estimated based on industry average for the Biotechnology Research industry and current estimated revenues | $3,300,000 |
| Total funding | $20,000,000 |
Key Contact at IdentifySensors
Kevin Amacker
Director of Quality
Company overview
| Headquarters | 20600 Chagrin Blvd, Cleveland, Ohio 44122, US |
| Phone number | +111614439 |
| Website | |
| NAICS | 541714 |
| SIC | 516 |
| Keywords | Supply Chain, Explosive & Chemical Sensing, Nano-Particle, Scintillator & Semi-Conductor Crystals |
| Founded | 2019 |
| Employees | 11-20 |
| Socials |
IdentifySensors Email Formats
IdentifySensors uses 1 email format. The most common is {first name}{last name} (e.g., johndoe@identifysensors.com), used 100% of the time.
| Format | Example | Percentage |
|---|---|---|
{first name}{last name} | johndoe@identifysensors.com | 100% |
About IdentifySensors
IdentifySensors is a leading developer of digital diagnostic technologies on graphene-based biosensors. The company is principally focused on developing real-time pathogen detection capabilities for direct diagnosis and remote monitoring. The company’s technology has expanded into multiple industries and applications, such as pathogen diagnostics and testing for food contamination. Check4® by IdentifySensors Biologics® is a next-generation digital diagnostic platform intended to detect multiple pathogens within 5 minutes at the molecular gene level. The platform is intended to eliminates the need for enzymatic amplification and reagents. Graphene-based sensor technology has moved diagnostics beyond chemical testing into a rapid digital platform intended to be as accurate as a PCR test but significantly more sensitive and cost effective. Printed graphene-based sensors isolate targeted viruses and bacteria from saliva and other bodily fluids within a handheld, Bluetooth device. The platform is intended to detect the genetic material of dozens of pathogens for over-the-counter and point-of-care use. With a target price at a fraction of current molecular tests, Check4® is intended to disrupt the PCR market for many infections. The Check4® testing platform comes is two main parts: 1) A reader, which connects to a user’s cell phone or to a clinical database; and 2) Single-use test cartridges, which can contain multiple graphene sensors to detect multiple infections. The reader, which can be reused thousands of times, serves as the base of the platform, accepting any number of test cartridges. Disposable test cartridges, which require the reader to work, will be sold separately.
Employees by Management Level
Total employees: 11-20
Seniority
Employees
IdentifySensors Tech Stack
Discover the technologies and tools that power IdentifySensors's digital infrastructure, from frameworks to analytics platforms.
Retargeting
Security
Cookie compliance
Maps
CDN
JavaScript libraries
Programming languages
Blogs
SEO
Analytics
JavaScript libraries
Frequently asked questions
4.8
40,000 users



